Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Date and Time: Tuesday 10 May 2022, 3:00 pm (UK BST)

To Join: This is a free event, which will be taking place online via Zoom. To register your interest in attending this talk please click HERE


The goal of this study is to measure losses in quality-adjusted life years (QALYs), via time trade-off questions, for COVID health states in a nationally representative sample of US adults. Health state descriptions were developed to intentionally include the uncertainty associated with COVID-19 illness as well as caregiver spillover.

Preliminary results for QALY losses for health states and caregiver impact will be presented along with some implications of these findings for the valuation of child health.

If time permits, preliminary results from a second study using a discrete choice experiment approach to understand the relative value of COVID vaccine- and vaccination-related attributes for children and adults will be presented.



Dr Lisa Prosser, Director, Susan B. Meister Child Health Evaluation and Research Center, University of MichiganDr. Lisa Prosser is Professor and Director of the Susan B. Meister Child Health Evaluation and Research Center at the University of Michigan. Her research focuses on measuring the value of childhood health interventions using methods of decision sciences and economics. Current research topics include newborn screening programs, vaccination programs, and methods for valuing family spillover effects of illness. She also uses quantitative survey methods (health utility assessment, conjoint analysis) to measure health-related quality of life and preferences for health interventions.

Dr. Prosser's research evaluating the cost-effectiveness of vaccination programs has been used in setting national vaccine policy for children and adults. Her work with the Evidence Review Group for the Advisory Committee on Heritable Disorders in Newborns and Children using decision science modeling to project long-term health outcomes for proposed newborn screening programs has been used to inform national newborn screening policy decisions. She is currently a member of the evidence review group for the Advisory Committee on Heritable Disorders in Newborns and Children and the ACIP Zoster Working Group.

Dr. Prosser has contributed to faculty development programs at the department, school, and institutional level. She currently serves as the Assistant Dean for Research Faculty at the Medical School. Dr. Prosser also holds an adjunct faculty appointment at the Harvard School of Public Health.